/ /

  • linkedin
  • Increase Font
  • Sharebar

    Time for a paradigm shift in the treatment of DME

     

    Clinical course

    Before treatment:

    •                VA:  20/60- OD

    •                IOP: 18 mm Hg

    •                OCT demonstrated chronic persistent cystoid macular edema (CME) – See Figure 1

    Courtesy of Joshua Mali, MD

     

    Post treatment 90 days with the implant:

    •                VA: 20/20 OD (patient stated that he now has the best vision he has ever had!)

    •                IOP: 21 mm Hg

    •                The implant was in an ideal location in the vitreous  

    •                No adverse reactions noted on clinical exam or subjectively by the patient.

    •                OCT demonstrated a sustained resolution of DME – See Figure 2

    Courtesy of Joshua Mali, MD

     

    Joshua Mali, MD, is a vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, Florida. He can be reached at 941-792-2020. He is currently a consultant and shareholder at Alimera Sciences and a consultant at Allergan, where he also conducts research and receives clinical study funding.

    New Call-to-action

     

    Joshua Mali, MD
    Joshua Mali, MD, is a vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, Florida.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results